Eisai Co., Ltd. Skip Navigation Top menu Japanese | English
| Sitemap |
Main menu  Investor Relationsselected  |  Environmental and Social Report  |  about Eisai  |  Inquiry
   Home > Investor Relations Main contents

Investor Relations

 Business Performance Highlights

  Performance Highlights, Research & Development

 Financial Information

  Annual Financial Results, Reference Data etc

 Presentations

  Financial Explanation, Information Meeting etc

 Annual Report

  Reports have been Issued since 1997

 IR Calendar

  Past and Upcoming IR Events

 Share Information

  Share Price Information etc

   General Meeting of Shareholders

 

 Bonds and Ratings

  Bond Issues, Ratings by Independent ratings agencies

 Analyst Coverage

  List of Analysts taking charge of Eisai

 IR Site Map

  Site Map on IR Page

 IR Inquiry

  Inquiry about Eisai
Investor Kit
   Latest Investor Kit is available for download

  News Release
list
July 30, 2010
Continuation of Policy for Protection of the Company's Corporate Value and Common Interests of Shareholders (Shareholder Rights Plan)
July 24, 2010
EISAI ANNOUNCES U.S. FDA APPROVAL FOR NEW HIGHER DOSE ARICEPT® 23 MG TABLET FOR THE TREATMENT OF MODERATE-TO-SEVERE ALZHEIMER’S DISEASE
July 20, 2010
FDA ACCEPTS BANZEL® (RUFINAMIDE) ORAL SUSPENSION NDA FOR REVIEW

  IR What's New
July 30, 2010
First Quarter Financial Results Explanation for the Fiscal Year Ending March 31, 2011 [Material]
July 30, 2010
First Quarter Financial Results for the Fiscal Year Ending March 31, 2011
July 29, 2010
Annual Report 2010

  Information
Notice of shareholder voting results for the 98th ordinary general meeting of shareholders (June 21, 2010)
Notice of resolutions of the 98th ordinary general meeting of shareholders (June 18, 2010)
Corporate Governance Report updated (March 31, 2010)
  Share Performance 
Open a separate window

     More Details
    (delayed 20 min.)
Side menu
Message for Investors
IR Cafe
Top 5 most viewed pages
(June 2010)
1. Presentations
2. Financial Reports
3. Business Performance Highlights
4. Consolidated/Non-Consolidated Annual Financial Report
5. General Meeting of Shareholders
E-mail Alerts


Bottom menu
   Privacy Policy  |   Terms of Use  |   Accessibility
Copyright(C) Eisai Co., Ltd All right reserved.